Can Slingshot Proteins be Targeted for Cancer Therapy?
Given their role in regulating cell motility and invasion, Slingshot proteins represent attractive targets for anti-metastatic therapies. Inhibitors that specifically block Slingshot activity could potentially hinder the metastatic spread of cancer by stabilizing the actin cytoskeleton and reducing cell motility. Current research is focused on developing such inhibitors and evaluating their efficacy in preclinical models.
